ResMed (RMD) Reports In-Line Q1 EPS
Get Alerts RMD Hot Sheet
Price: $183.78 --0%
Revenue Growth %: +4.8%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Revenue Growth %: +4.8%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) tops Q1 earnings, revenue estimates; FY guidance updated
- Opera Limited (OPRA) Misses Q1 EPS by 5c, provides guidance
- Bristol-Myers Squibb (BMY) Tops Q1 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!